How do natural killer cells detect infected cells?
28 May 2025
Introduction to Natural Killer Cells
Natural killer (NK) cells are a critical component of the innate immune system, acting as the body's first line of defense against virally infected and cancerous cells. Unlike other immune cells, NK cells can recognize and respond to infected cells without prior sensitization, making them essential for early immune responses. This blog explores the fascinating mechanisms by which NK cells identify and target infected cells, contributing to the body's overall immune defense.
Understanding NK Cell Activation
NK cells are equipped with a diverse array of receptors that enable them to detect changes on the surface of potential target cells. These receptors are broadly categorized into activating and inhibitory receptors. The balance between signals from these receptors determines the activation state of an NK cell.
1. Activating Receptors: These receptors recognize stress-induced ligands on the surface of infected or transformed cells. When these ligands are present, activating receptors stimulate NK cells to attack the target cell. Some well-known activating receptors include NKG2D and NKp30.
2. Inhibitory Receptors: To prevent unwanted destruction of healthy cells, NK cells also possess inhibitory receptors that recognize normal "self" molecules, typically major histocompatibility complex (MHC) class I molecules. When these molecules are detected, the inhibitory signals prevent the NK cell from launching an attack.
The Missing Self Hypothesis
One of the pivotal concepts in NK cell-mediated detection is the "missing self" hypothesis. This theory suggests that NK cells are activated when they encounter cells with reduced or absent MHC class I expression. Many viruses and cancerous transformations lead to downregulation of MHC class I molecules, allowing NK cells to recognize these targets as "missing self" and initiate a cytotoxic response.
Stress-Induced Ligands and NK Cell Recognition
Infected and stress-related alterations in cells often lead to the expression of stress-induced ligands, which are not typically present on healthy cells. These ligands are recognized by specific activating receptors on NK cells. For instance, in response to viral infections or cellular stress, molecules like MIC-A/B and ULBPs may be upregulated, serving as signals for NK cells to eliminate the distressed cells.
Role of Cytokines in NK Cell Activity
Cytokines are soluble molecules that play a vital role in the activation and regulation of NK cells. Interleukin-12 (IL-12), interleukin-15 (IL-15), and interleukin-18 (IL-18) are key cytokines that enhance the cytotoxic activity of NK cells. These cytokines help to prime NK cells, increasing their ability to detect and destroy infected cells effectively.
The Cytotoxic Mechanism of NK Cells
Once an NK cell has identified a target cell, it employs several mechanisms to kill the infected or malignant cell.
1. Perforin and Granzymes: NK cells release cytotoxic granules containing perforin and granzymes. Perforin forms pores in the target cell membrane, allowing granzymes to enter and induce apoptosis.
2. Death Receptor Pathway: NK cells can also engage death receptors on the target cell surface, such as Fas ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL), triggering programmed cell death.
Conclusion
Natural killer cells are indispensable players in the body's defense against infections and tumors. Their ability to detect and eliminate infected cells without prior sensitization is a testament to the sophistication of the innate immune system. By understanding the mechanisms of NK cell recognition and activation, researchers continue to explore potential therapeutic applications, including NK cell-based immunotherapies for cancer and infectious diseases. The ongoing study of NK cells not only expands our knowledge of immunology but also holds promise for innovative treatments in the future.
Discover Eureka LS: AI Agents Built for Biopharma Efficiency
Stop wasting time on biopharma busywork. Meet Eureka LS - your AI agent squad for drug discovery.
▶ See how 50+ research teams saved 300+ hours/month
From reducing screening time to simplifying Markush drafting, our AI Agents are ready to deliver immediate value. Explore Eureka LS today and unlock powerful capabilities that help you innovate with confidence.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.